Donald E. Pogorzelski

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA.

Sekisui Diagnostics LLC provides drug development, genetic testing and other services. Its product lines include clinical chemistry systems and reagents, coagulation systems and reagents, point of care rapid tests and immunoassay system, enzymes and specialty biochemicals. The company was founded in 1981 and is headquartered in Lexington, MA.

New England Baptist Hospital provides orthopedic surgery and the treatment of musculoskeletal diseases and disorders. Its services include orthopedics, general surgery, medical services, patient care services, and programs. The company was founded by Francis Fremont Whittier in 1893 and is headquartered in Boston, MA.

DG Tech Investors, Inc. develops DNA testing products. It offers RapidTip, a single-use functional pipette tip for purifying polymerase chain reaction amplicons. The firm also develops products for nucleic acid isolation and analysis. The company was founded by Rothberg J. Lewis, Riedlinger D. Michael, Li Hiuxiang and Richmond Rick in 2005 and is headquartered in West Henrietta, NY.

PrismHealthDX, Inc. engages in the provision of precision diagnostics and chronic disease management services. It focuses on enterprising innovation and development of clinical diagnostic and disease management capabilities; root-cause disease characterization; and education and wellness tracking solutions. The company was founded in 2015 and is headquartered in Austin, TX.